The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.